Norica Nichita

Dr. Norica Nichita

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2013 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
AMAlina Macovei
Alina Macovei
CPCatalina Petrareanu
Catalina Petrareanu
Catalin LazarCatalin Lazar
Catalin Lazar
PFPaula Ecaterina Florian
Paula Ecaterina Florian
NNNorica Nichita
Norica Nichita
Despite important progress toward deciphering human hepatitis B virus (HBV) entry into host cells, many aspects of the early steps of the life cycle remained completely obscure. Following endocytosis, HBV must travel through the complex network of the endocytic pathway to reach the cell nucleus and initiate replication. In addition to guiding the viral particles to the replication site, the endosomal vesicles may play a crucial role in infection, providing the appropriate environment for virus uncoating and nucleocapsid release. In this work, we investigated the trafficking of HBV particles internalized in permissive cells. Expression of key Rab proteins, involved in specific pathways leading to different intracellular locations, was modulated in HepaRG cells, using a stable and inducible short hairpin RNA (shRNA) expression system. The trafficking properties of the newly developed cells were demonstrated by confocal microscopy and flow cytometry using specific markers. The results showed that HBV infection strongly depends on Rab5 and Rab7 expression, indicating that HBV transport from early to mature endosomes is required for a step in the viral life cycle. This may involve reduction of disulfide bond-linked envelope proteins, as alteration of the redox potential of the endocytic pathway resulted in inhibition of infection. Subcellular fractionation of HBV-infected cells showed that viral particles are further transported to lysosomes. Intriguingly, infection was not dependent on the lysosomal activity, suggesting that trafficking to this compartment is a “dead-end” route. Together, these data add to our understanding of the HBV-host cell interactions controlling the early stages of infection.

1 January 2010 in Journal of Virology
Verified
Journal Article
Closed access
AMAlina Macovei
Alina Macovei
CRCristina Radulescu
Cristina Radulescu
Catalin LazarCatalin Lazar
Catalin Lazar
SPStefana M. Petrescu
Stefana M. Petrescu
DDDavid Durantel
David Durantel
NNNorica Nichita
Norica Nichita
Investigation of the entry pathways of hepatitis B virus (HBV), a member of the familyHepadnaviridae, has been hampered by the lack of versatile in vitro infectivity models. Most concepts of hepadnaviral infection come from the more robust duck HBV system; however, whether the two viruses use the same mechanisms to invade target cells is still a matter of controversy. In this study, we investigate the role of an important plasma membrane component, caveolin-1 (Cav-1), in HBV infection. Caveolins are the main structural components of caveolae, plasma membrane microdomains enriched in cholesterol and sphingolipids, which are involved in the endocytosis of numerous ligands and complex signaling pathways within the cell. We used the HepaRG cell line permissive for HBV infection to stably express dominant-negative Cav-1 and dynamin-2, a GTPase involved in vesicle formation at the plasma membrane and other organelles. The endocytic properties of the newly established cell lines, designated HepaRGCav-1, HepaRGCav-1Δ1-81, HepaRGDyn-2, and HepaRGDyn-2K44A, were validated using specific markers for different entry routes. The cells maintained their properties during cell culture, supported differentiation, and were permissive for HBV infection. The levels of both HBV transcripts and antigens were significantly decreased in cells expressing the mutant proteins, while viral replication was not directly affected. Chemical inhibitors that specifically inhibit clathrin-mediated endocytosis had no effect on HBV infection. We concluded that HBV requires a Cav-1-mediated entry pathway to initiate productive infection in HepaRG cells.

10 April 2014 in Soft Matter
Verified
Journal Article
Closed access
PDF file
NHNicolae Hurduc
Nicolae Hurduc
BDBogdan Donose
Bogdan Donose
AMAlina Macovei
Alina Macovei
CPCristina Paius
Cristina Paius
CIConstanța Ibănescu
Constanța Ibănescu
LRLicinio Rocha
Licinio Rocha
Light induced fluidization of azopolysiloxane: exposure to 488 nm light generates instantaneous mass transfer as a result of trans – cis isomerization in azophenol polymers. Viscoelastic mapping confirms the changes of rheological properties upon exposure to the light.

2 August 2012 in Proteome Science
Verified
Journal Article
Open access
PDF file
ISIzabela Sokolowska
Izabela Sokolowska
CDCristina Dorobantu
Cristina Dorobantu
AWAlisa G Woods
Alisa G Woods
AMAlina Macovei
Alina Macovei
NNNorica Nichita
Norica Nichita
Costel DarieCostel Darie
Costel Darie
Liver infection with hepatitis B virus (HBV), a DNA virus of the Hepadnaviridae family, leads to severe disease, such as fibrosis, cirrhosis and hepatocellular carcinoma. The early steps of the viral life cycle are largely obscure and the host cell plasma membrane receptors are not known. HepaRG is the only proliferating cell line supporting HBV infection in vitro, following specific differentiation, allowing for investigation of new host host-cell factors involved in viral entry, within a more robust and reproducible environment. Viral infection generally begins with receptor recognition at the host cell surface, following highly specific cell-virus interactions. Most of these interactions are expected to take place at the plasma membrane of the HepaRG cells. In the present study, we used this cell line to explore changes between the plasma membrane of undifferentiated (−) and differentiated (+) cells and to identify differentially-regulated proteins or signaling networks that might potentially be involved in HBV entry. Our initial study identified a series of proteins that are differentially expressed in the plasma membrane of (−) and (+) cells and are good candidates for potential cell-virus interactions. To our knowledge, this is the first study using functional proteomics to study plasma membrane proteins from HepaRG cells, providing a platform for future experiments that will allow us to understand the cell-virus interaction and mechanism of HBV viral infection.

15 December 2011 in Journal of Virology
Verified
Journal Article
Closed access
CDCristina Dorobantu
Cristina Dorobantu
AMAlina Macovei
Alina Macovei
Catalin LazarCatalin Lazar
Catalin Lazar
RDRaymond A. Dwek
Raymond A. Dwek
NZNicole Zitzmann
Nicole Zitzmann
NNNorica Nichita
Norica Nichita
Previous reports have shown that cholesterol depletion of the membrane envelope of the hepatitis B virus (HBV) impairs viral infection of target cells. A potential function of this lipid in later steps of the viral life cycle remained controversial, with secretion of virions and subviral particles (SVP) being either inhibited or not affected, depending on the experimental approach employed to decrease the intracellular cholesterol level. This work addressed the role of host cell cholesterol on HBV replication, assembly, and secretion, using an alternative method to inhibition of the enzymes involved in the biosynthesis pathway. Growing HBV-producing cells with lipoprotein-depleted serum (LPDS) resulted in an important reduction of the amount of cholesterol within 24 h of treatment (about 40%). Cell exposure to chlorpromazine, an inhibitor of the clathrin-mediated pathway used by the low-density lipoprotein receptor for endocytosis, also impacted the cholesterol level; however, this level of inhibition was not achievable when the synthesis inhibitor lovastatin was used. HBV secretion was significantly inhibited in cholesterol-depleted cells (by ∼80%), while SVP release remained unaffected. The viral DNA genome accumulated in LPDS-treated cells in a time-dependent manner. Specific immunoprecipitation of nucleocapsids and mature virions revealed an increased amount of naked nucleocapsids, while synthesis of the envelope proteins occurred as normally. Following analysis of the large envelope protein conformation in purified microsomes, we concluded that cholesterol is important in maintaining the dual topology of this polypeptide, which is critical for viral envelopment.

4 June 2020 in Cells
Verified
Journal Article
Open access
PDF file
MDMihaela-Olivia Dobrica
Mihaela-Olivia Dobrica
Catalin LazarCatalin Lazar
Catalin Lazar
NNNorica Nichita
Norica Nichita
Hepatitis B Virus (HBV) glycobiology has been an area of intensive research in the last decades and continues to be an attractive topic due to the multiple roles that N-glycosylation in particular plays in the virus life-cycle and its interaction with the host that are still being discovered. The three HBV envelope glycoproteins, small (S), medium (M) and large (L) share a very peculiar N-glycosylation pattern, which distinctly regulates their folding, degradation, assembly, intracellular trafficking and antigenic properties. In addition, recent findings indicate important roles of N-linked oligosaccharides in viral pathogenesis and evasion of the immune system surveillance. This review focuses on N-glycosylation’s contribution to HBV infection and disease, with implications for development of improved vaccines and antiviral therapies.